Moreover, many genes (e.g., TFF1, LOC440335, SLC39A6, HOXA9, and FOXA1) identified by the current study have been well evidenced to be related to play driving or regulating roles in tumor chemotherapy drug resistance in the context of breast cancer. This evidence concerns the gene SLC39A6 and breast cancer.